The Redefining Early Stage Investments (RESI) conference series was created by Life Science Nation (LSN) to bring together startups with early-stage investors and strategic channel partners. The goal was to maximize the capability of these companies, from seed to series B, to find partners who are a fit for their technology and stage of development. What‘s unique about RESI is that the event is cross border and cross domain, connecting startups with 10 categories of global investors across the silos of drugs, devices, diagnostics and digital health, the “4 Ds”. RESI caters to both the earliest stage startups, those seeking grants, seed and angel capital, and the early-stage firms who seek series A and B funding.
We estimate that our RESI and Investor platform has helped over 300 companies raise over $400 million. For the first time, RESI will be heading to Asia in November, with two events in one week – RESI Shanghai on November 12th, and RESI Taipei on November 14th.
- Meet Technology Assets from China, North America, Europe, Pacific Rim & Taiwan
- Asia Investors Meet North American & European Investors for Partnerships
- Connect Your Portfolio Companies to Service Providers and Distribution Channels in Asia Market
|RESI ASIA Therapeutics Companies|
|RESI ASIA Medical Device Companies|
|RESI ASIA Diagnostics Companies|
|RESI ASIA Digital Health Companies|